Literature DB >> 25242329

Apicobasal polarity controls lymphocyte adhesion to hepatic epithelial cells.

Natalia Reglero-Real1, Adrián Álvarez-Varela1, Eva Cernuda-Morollón2, Jorge Feito3, Beatriz Marcos-Ramiro1, Laura Fernández-Martín1, Maria José Gómez-Lechón4, Jordi Muntané5, Pilar Sandoval1, Pedro L Majano6, Isabel Correas1, Miguel A Alonso1, Jaime Millán7.   

Abstract

Loss of apicobasal polarity is a hallmark of epithelial pathologies. Leukocyte infiltration and crosstalk with dysfunctional epithelial barriers are crucial for the inflammatory response. Here, we show that apicobasal architecture regulates the adhesion between hepatic epithelial cells and lymphocytes. Polarized hepatocytes and epithelium from bile ducts segregate the intercellular adhesion molecule 1 (ICAM-1) adhesion receptor onto their apical, microvilli-rich membranes, which are less accessible by circulating immune cells. Upon cell depolarization, hepatic ICAM-1 becomes exposed and increases lymphocyte binding. Polarized hepatic cells prevent ICAM-1 exposure to lymphocytes by redirecting basolateral ICAM-1 to apical domains. Loss of ICAM-1 polarity occurs in human inflammatory liver diseases and can be induced by the inflammatory cytokine tumor necrosis factor alpha (TNF-α). We propose that adhesion receptor polarization is a parenchymal immune checkpoint that allows functional epithelium to hamper leukocyte binding. This contributes to the haptotactic guidance of leukocytes toward neighboring damaged or chronically inflamed epithelial cells that expose their adhesion machinery.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25242329     DOI: 10.1016/j.celrep.2014.08.007

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  7 in total

Review 1.  Parallels between single cell migration and barrier formation: The case of RhoB and Rac1 trafficking.

Authors:  Diego García-Weber; Jaime Millán
Journal:  Small GTPases       Date:  2016-09-30

2.  Clathrin-dependent entry and vesicle-mediated exocytosis define insulin transcytosis across microvascular endothelial cells.

Authors:  Paymon M Azizi; Roman E Zyla; Sha Guan; Changsen Wang; Jun Liu; Steffen-Sebastian Bolz; Bryan Heit; Amira Klip; Warren L Lee
Journal:  Mol Biol Cell       Date:  2014-12-24       Impact factor: 4.138

3.  Release of HIV-1 sequestered in the vesicles of oral and genital mucosal epithelial cells by epithelial-lymphocyte interaction.

Authors:  Aizezi Yasen; Rossana Herrera; Kristina Rosbe; Kathy Lien; Sharof M Tugizov
Journal:  PLoS Pathog       Date:  2017-02-27       Impact factor: 6.823

4.  Plasmolipin regulates basolateral-to-apical transcytosis of ICAM-1 and leukocyte adhesion in polarized hepatic epithelial cells.

Authors:  Cristina Cacho-Navas; Natalia Reglero-Real; Natalia Colás-Algora; Susana Barroso; Gema de Rivas; Kostantinos Stamatakis; Jorge Feito; Germán Andrés; Manuel Fresno; Leonor Kremer; Isabel Correas; Miguel A Alonso; Jaime Millán
Journal:  Cell Mol Life Sci       Date:  2022-01-09       Impact factor: 9.261

5.  Possible Role of Extracellular Vesicles in Hepatotoxicity of Acetaminophen.

Authors:  Martina Šrajer Gajdošik; Anamarija Kovač Peić; Marija Begić; Petra Grbčić; Kate E Brilliant; Douglas C Hixson; Djuro Josić
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

Review 6.  Cellular Barriers after Extravasation: Leukocyte Interactions with Polarized Epithelia in the Inflamed Tissue.

Authors:  Natalia Reglero-Real; Diego García-Weber; Jaime Millán
Journal:  Mediators Inflamm       Date:  2016-01-28       Impact factor: 4.711

7.  RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell border.

Authors:  Beatriz Marcos-Ramiro; Diego García-Weber; Susana Barroso; Jorge Feito; María C Ortega; Eva Cernuda-Morollón; Natalia Reglero-Real; Laura Fernández-Martín; Maria C Durán; Miguel A Alonso; Isabel Correas; Susan Cox; Anne J Ridley; Jaime Millán
Journal:  J Cell Biol       Date:  2016-05-02       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.